Understanding Alzheimer’s risk and resilience in Black Americans over 20 years

ADRD risk and resilience among Black Americans: A 20-year longitudinal study

NIH-funded research University of Michigan at Ann Arbor · NIH-11051397

This study is looking at what helps or hurts brain health in Black Americans, especially since they are more likely to face Alzheimer's and similar conditions, and it aims to find ways to support better cognitive health for middle-aged and older adults from different backgrounds across the country.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-11051397 on NIH RePORTER

What this research studies

This research investigates the factors that influence cognitive health among Black Americans, who are at a higher risk for Alzheimer's disease and related dementias. By analyzing data from a long-term survey, the study aims to identify both risk and protective factors affecting cognitive functioning in middle-aged and older adults. Participants will be drawn from a diverse range of backgrounds across the United States, allowing for a comprehensive understanding of how various psychosocial and environmental factors contribute to cognitive health. The findings could inform culturally relevant prevention and intervention strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research include Black adults and adolescents, particularly those in middle-age or older, who may be at risk for cognitive decline.

Not a fit: Patients who are not of Black descent or those who are not within the age range of middle-aged to older adults may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing Alzheimer's disease and related dementias in Black Americans.

How similar studies have performed: Previous research has shown success in identifying risk factors for cognitive decline in diverse populations, but this specific longitudinal approach focusing on Black Americans is relatively novel.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.